Program Description
This interactive module provides an in-depth analysis of current guidelines asthma management, based on research findings from three organizations/groups:
- The American Thoracic Society (ATS), in conjunction with the European Respiratory Society (ERS), recently completed guidelines for severe asthma.
- The U.S. National Asthma Education and Prevention Program (NAEPP), launched in 1989, oversees the development of asthma guidelines (e.g., Expert Panel Reports) and coordinates federal asthma-related activities.
- The Global Initiative for Asthma (GINA), launched in 1993, develops resources such as evidence-based strategy documents and pocket guides for asthma management that are updated annually.
This course is an edited and enhanced recording of the ATS 2021 International Conference session with the same name.
Target Audience
Providers of asthma care; those with clinical, research, or administrative responsibilities in asthma; those involved in developing asthma guidelines; those involved in quality improvement or value-based care efforts.
Learning Objectives
After successfully completing this module, learners will be able to:
- Outline the guideline recommendations for severe asthma
- Outline the guideline recommendations for mild asthma
- Explain the role of guidelines in improving asthma care and outcomes
Course summary
1.50 Participation
1.50 AMA PRA Category 1 Credit
Credit Expires: September 28, 2023
Format: Interactive Module(s)
| Name | Title | Institution | Role | Relationship |
| Andrew Bush, MD | Professor; Co-chair, Joint ERS/ATS Guidelines Task Force | Imperial College & Royal Brompton Hospital | Presenter | None |
| Fernando D. Martinez, MD | Professor | The University of Arizona Asthma & Airway Disease Research Center | Presenter | OM Pharma SA: Research - investigator initiated NHLBI: HL139054 Research - investigator initiated; HL130045 Research - investigator initiated; HL132523 Research - investigator initiated; HL147016 Research - investigator initiated; HL147016 Research - investigator initiated; U01HL138626: Research - investigator initiated NHLBI-NIAMS Workshop: Speaker/faculty - non-promotional purpose NIAID: AI135108 Research - investigator initiated; AI146131 Research - investigator initiated; AI148104 Research - investigator initiated; U01AI126614 Research - investigator initiated NIH-OD023282: Research - investigator initiated OMNIPREX: Speaker/faculty - non-promotional purpose Childrens Hospital Los Angeles: Speaker/faculty - non-promotional purpose Japanese Society of Pediatric Allergy andClinic: Speaker/faculty - non-promotional purpose American Academy of Allergy, Asthma, and Immunolog: Speaker/faculty - non-promotional purpose NYU Langone Health: Speaker/faculty - non-promotional purpose Asthma UK Centre for Applied Research: Advisory Committee - non-promotional Italian Society of Rhinology: Speaker/faculty - non-promotional purpose Chilean Society of Pediatrics: Speaker/faculty - non-promotional purpose |
| Helen K. Reddel, MD | Professor; Chair, GINA Science Committee | Woolcock Institute of Medical Research, Sydney, Australia | Presenter | GlaxoSmithKline: Speaker/faculty - non-promotional purpose; Research - investigator initiated Teva: Speaker/faculty - non-promotional purpose Novartis: Advisory Committee - non-promotional; Research - investigator initiated AstraZeneca: Advisory Committee - non-promotional; Speaker/faculty - non-promotional purpose; Research - investigator initiated Chiesi: Advisory Committee - non-promotional Sanofi: Advisory Committee - non-promotional |
| Michelle M. Cloutier, MD | Professor Emerita, Pediatrics & Medicine | University of Connecticut (UCONN Health) | Presenter | None |
ACCREDITATION STATEMENT
The American Thoracic Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
| Credit Type | Credit/Points | Credit Designation Statement |
| AMA PRA Category 1 Credit™ | 1.50 | The American Thoracic Society designates this Interactive Module(s) for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
DISCLOSURE DECLARATIONS
It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships are present. To see the most recent policies regarding potential conflicts of interest as well as the mechanisms to resolve such conflicts, press the COI Policy link below.
This educational activity may include discussion of unapproved uses of a drug, product, or device. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
INSTRUCTIONS TO RECEIVE CREDIT
To earn credit for this course, follow these instructions:
- Launch and complete all modules by viewing every page in the module.
- After you complete the module(s), the post test will become available. You must pass the post these with a 70% score or better.
- Complete the course evaluation.
- Once you complete the modules, pass the post-test and complete the evaluation, the system will grant you credit.
- To view your transcript and print your certificate, go to the My Learning drop-down list. Then select Transcript.